Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
International Society on Thrombosis and Haemostasis - 34th Congress, 2026 (ISTH)11 - 15 July 2026
Inno8, the first orally administered factor VIII mimetic shows favorable safety, pharmacokinetic, and pharmacodynamic properties in healthy male participants
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.